Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a

Oncogene

Volumn 26, Issue 50, 2007, Pages 7081-7091

  Ticchioni, M ^a   Essafi, M ^a   Jeandel, P Y ^a   Davi, F ^b   Cassuto, J P ^a   Deckert, M ^a   Bernard, A ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Akt; B CLL; Chemokines; FOXO3a; Survival

Indexed keywords

CD5 ANTIGEN; CHEMOKINE; CXCL13 CHEMOKINE; GLYCOGEN SYNTHASE KINASE 3; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN P90RSK; SECONDARY LYMPHOID TISSUE CHEMOKINE; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL DEATH; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOID CELL; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; APOPTOSIS; CELL DEATH; CELL SURVIVAL; CHEMOKINES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HOMEOSTASIS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; TRANS-ACTIVATION (GENETICS);

EID: 35948946952     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210519     Document Type: Article

References (35)

1. Aubin J, Davi F, Nguyen-Salomon F, Leboeuf D, Debert C, Taher M et al. (1995). Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 9: 471-479.
2. Baccarini M. (2002). An old kinase on a new path: Raf and apoptosis. Cell Death Differ 9: 783-785.
3. Birkenkamp KU, Coffer PJ. (2003). FOXO transcription factors as regulators of immune homeostasis: molecules to die for? J Immunol 171: 1623-1629.
4. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
5. Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell'Aquila M, Kipps TJ. (2000). Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 96: 2655-2663.
6. Burger M, Hartmann T, Krome M, Rawluk J, Tamamura H, Fujii N et al. (2005). Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood 106: 1824-1830.
7. Burgering BM, Medema RH. (2003). Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol 73: 689-701.
8. Caligaris-Cappio F, Hamblin TJ. (1999). B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 17: 399-408.
9. Charvet C, Alberti I, Luciano F, Jacquel A, Bernard A, Auberger P et al. (2003). Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3-like proteases. Oncogene 22: 4557-4568.
10. Colamussi ML, Secchiero P, Gonelli A, Marchisio M, Zauli G, Capitani S. (2001). Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional upregulation of the Fas (CD95)/Fas ligand (CD95L) pathway. J Leukoc Biol 69: 263-270.
11. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M et al. (2003). ZAP-70 expression as a surrogate for immunoglobulin-variable- region mutations in chronic lymphocytic leukemia. N Engl J Med 348: 1764-1775.
12. Durig J, Naschar M, Schmucker U, Renzing-Kohler K, Holter T, Huttmann A et al. (2002). CD38 expression is an important prognostic marker in chronic lymphocytic leukemia. Leukemia 16: 30-35.
13. Eldar-Finkelman H. (2002). Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med 8: 126-132.
14. Glimm H, Tang P, Clark-Lewis I, von Kalle C, Eaves C. (2002). Ex vivo treatment of proliferating human cord blood stem cells with stroma-derived factor-1 enhances their ability to engraft NOD/SCID mice. Blood 99: 3454-3457.
15. Hodohara K, Fujii N, Yamamoto N, Kaushansky K. (2000). Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK). Blood 95: 769-775.
16. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY et al. (2004). IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225-237.
17. Kamiguti AS, Harris RJ, Slupsky JR, Baker PK, Cawley JC, Zuzel M. (2003). Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways. Oncogene 22: 2272-2284.
18. Kipps TJ. (2003). Immunobiology of chronic lymphocytic leukemia. Curr Opin Hematol 10: 312-318.
19. Lataillade JJ, Clay D, Bourin P, Herodin F, Dupuy C, Jasmin C et al. (2002). Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 99: 1117-1129.
20. Lee Y, Gotoh A, Kwon HJ, You M, Kohli L, Mantel C et al. (2002). Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines. Blood 99: 4307-4317.
21. Leupin N, Cenni B, Novak U, Hugli B, Graber HU, Tobler A et al. (2003). Disparate expression of the PTEN gene: a novel finding in B-cell chronic lymphocytic leukaemia (B-CLL). Br J Haematol 121: 97-100.
22. Luther SA, Cyster JG. (2001). Chemokines as regulators of T cell differentiation. Nat Immunol 2: 102-107.
23. Majka M, Janowska-Wieczorek A, Ratajczak J, Kowalska MA, Vilaire G, Pan ZK et al. (2000). Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis. Blood 96: 4142-4151.
24. Mori M, Uchida M, Watanabe T, Kirito K, Hatake K, Ozawa K et al. (2003). Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling. J Cell Physiol 195: 290-297.
25. Moser B, Loetscher P. (2001). Lymphocyte traffic control by chemokines. Nat Immunol 2: 123-128.
26. Nagata Y, Todokoro K. (1999). Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94: 853-863.
27. Nishio M, Endo T, Tsukada N, Ohata J, Kitada S, Reed JC et al. (2005). Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha. Blood 106: 1012-1020.
28. Okada T, Ngo VN, Ekland EH, Forster R, Lipp M, Littman DR et al. (2002). Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J Exp Med 196: 65-75.
29. Pepper C, Thomas A, Hoy T, Milligan D, Bentley P, Fegan C. (2003). The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood 101: 2454-2460.
30. Ringshausen I, Schneller F, Bogner C, Hipp S, Duyster J, Peschel C et al. (2002). Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta. Blood 100: 3741-3748.
31. Suzuki Y, Rahman M, Mitsuya H. (2001). Diverse transcriptional response of CD4(+) T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4(+) T cells. J Immunol 167: 3064-3073.
32. Ticchioni M, Charvet C, Noraz N, Lamy L, Steinberg M, Bernard A et al. (2002). Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration. Blood 99: 3111-3118.
33. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL et al. (2003). Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17: 2257-2317.
34. Vivanco I, Sawyers CL. (2002). The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501.
35. von Andrian UH, Mackay CR. (2000). T-cell function and migration. Two sides of the same coin. N Engl J Med 343: 1020-1034.